Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ]
The definition of borderline ovarian tumors is pathological. It is based on the combination of several histological criteria established by Hart and Norris and reviewed by Scully et al: pluristratification and epithelial budding, increased mitotic activity which can be very variable, cytonuclear aty...
Gespeichert in:
Veröffentlicht in: | International journal of innovation and applied studies 2014-07, Vol.7 (1), p.103 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | fre |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 103 |
container_title | International journal of innovation and applied studies |
container_volume | 7 |
creator | Benabdjalil, Y Mezane, S Achenani, M Hafidi, R Babahabib, A El Hassani, M Kaouach, J Moussaoui, D Dehayni, M |
description | The definition of borderline ovarian tumors is pathological. It is based on the combination of several histological criteria established by Hart and Norris and reviewed by Scully et al: pluristratification and epithelial budding, increased mitotic activity which can be very variable, cytonuclear atypia (differential diagnosis with benign tumors), absence of stromal invasion (differential diagnosis of malignant tumors). Serous tumors represent approximately 55% of borderline tumors. They are bilateral in 28-50% of cases. This histological type is, however, more often associated with extra-ovarian locations, as found in 30% of cases on average peritoneal implants, whose detection is fundamental because the class tumor stage III. Staging should be as complete as possible and should be as far as possible during the initial surgical resection. A restaging should be made when the initial staging is incomplete. Restaging does not affect patient survival but used to evaluate the prognosis of the initial tumor. Its indication still remains controversial: it is recommended for early-stage tumors, for which the treatment is now well codified. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1556059748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3413222031</sourcerecordid><originalsourceid>FETCH-proquest_journals_15560597483</originalsourceid><addsrcrecordid>eNqNzs1KA0EMB_BBECzadwh48FTYb7dnUbzbm0iJ3VSn7M7UZLLi23j1Jbz0xcxCBY8eQiD550dO3KzIinaxLIvqzM1FdlmW5WWVt00zc98rHUgZ5PDFpELwHLkj7n0gEJvHET2TgFXCkAQOn7DnuI8C3ZUG2KAAjrSxwKgEHUGP0PuUzMOkTPAID8RR5a-cdIhmbyeeP-x2QB98eAH8xaOlzCbA0E22p_cpn15p0uloP1240y32QvNjP3eXd7erm_uFMW9qP693UTnYap3XdZPVy-uqLf-X-gFyKmoU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1556059748</pqid></control><display><type>article</type><title>Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ]</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Benabdjalil, Y ; Mezane, S ; Achenani, M ; Hafidi, R ; Babahabib, A ; El Hassani, M ; Kaouach, J ; Moussaoui, D ; Dehayni, M</creator><creatorcontrib>Benabdjalil, Y ; Mezane, S ; Achenani, M ; Hafidi, R ; Babahabib, A ; El Hassani, M ; Kaouach, J ; Moussaoui, D ; Dehayni, M</creatorcontrib><description>The definition of borderline ovarian tumors is pathological. It is based on the combination of several histological criteria established by Hart and Norris and reviewed by Scully et al: pluristratification and epithelial budding, increased mitotic activity which can be very variable, cytonuclear atypia (differential diagnosis with benign tumors), absence of stromal invasion (differential diagnosis of malignant tumors). Serous tumors represent approximately 55% of borderline tumors. They are bilateral in 28-50% of cases. This histological type is, however, more often associated with extra-ovarian locations, as found in 30% of cases on average peritoneal implants, whose detection is fundamental because the class tumor stage III. Staging should be as complete as possible and should be as far as possible during the initial surgical resection. A restaging should be made when the initial staging is incomplete. Restaging does not affect patient survival but used to evaluate the prognosis of the initial tumor. Its indication still remains controversial: it is recommended for early-stage tumors, for which the treatment is now well codified.</description><identifier>EISSN: 2028-9324</identifier><language>fre</language><publisher>Rabat: International Journal of Innovation and Applied Studies</publisher><ispartof>International journal of innovation and applied studies, 2014-07, Vol.7 (1), p.103</ispartof><rights>Copyright International Journal of Innovation and Applied Studies Jul 2014</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Benabdjalil, Y</creatorcontrib><creatorcontrib>Mezane, S</creatorcontrib><creatorcontrib>Achenani, M</creatorcontrib><creatorcontrib>Hafidi, R</creatorcontrib><creatorcontrib>Babahabib, A</creatorcontrib><creatorcontrib>El Hassani, M</creatorcontrib><creatorcontrib>Kaouach, J</creatorcontrib><creatorcontrib>Moussaoui, D</creatorcontrib><creatorcontrib>Dehayni, M</creatorcontrib><title>Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ]</title><title>International journal of innovation and applied studies</title><description>The definition of borderline ovarian tumors is pathological. It is based on the combination of several histological criteria established by Hart and Norris and reviewed by Scully et al: pluristratification and epithelial budding, increased mitotic activity which can be very variable, cytonuclear atypia (differential diagnosis with benign tumors), absence of stromal invasion (differential diagnosis of malignant tumors). Serous tumors represent approximately 55% of borderline tumors. They are bilateral in 28-50% of cases. This histological type is, however, more often associated with extra-ovarian locations, as found in 30% of cases on average peritoneal implants, whose detection is fundamental because the class tumor stage III. Staging should be as complete as possible and should be as far as possible during the initial surgical resection. A restaging should be made when the initial staging is incomplete. Restaging does not affect patient survival but used to evaluate the prognosis of the initial tumor. Its indication still remains controversial: it is recommended for early-stage tumors, for which the treatment is now well codified.</description><issn>2028-9324</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNzs1KA0EMB_BBECzadwh48FTYb7dnUbzbm0iJ3VSn7M7UZLLi23j1Jbz0xcxCBY8eQiD550dO3KzIinaxLIvqzM1FdlmW5WWVt00zc98rHUgZ5PDFpELwHLkj7n0gEJvHET2TgFXCkAQOn7DnuI8C3ZUG2KAAjrSxwKgEHUGP0PuUzMOkTPAID8RR5a-cdIhmbyeeP-x2QB98eAH8xaOlzCbA0E22p_cpn15p0uloP1240y32QvNjP3eXd7erm_uFMW9qP693UTnYap3XdZPVy-uqLf-X-gFyKmoU</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Benabdjalil, Y</creator><creator>Mezane, S</creator><creator>Achenani, M</creator><creator>Hafidi, R</creator><creator>Babahabib, A</creator><creator>El Hassani, M</creator><creator>Kaouach, J</creator><creator>Moussaoui, D</creator><creator>Dehayni, M</creator><general>International Journal of Innovation and Applied Studies</general><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>F28</scope><scope>FR3</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>M7S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope></search><sort><creationdate>20140701</creationdate><title>Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ]</title><author>Benabdjalil, Y ; Mezane, S ; Achenani, M ; Hafidi, R ; Babahabib, A ; El Hassani, M ; Kaouach, J ; Moussaoui, D ; Dehayni, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_15560597483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2014</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Benabdjalil, Y</creatorcontrib><creatorcontrib>Mezane, S</creatorcontrib><creatorcontrib>Achenani, M</creatorcontrib><creatorcontrib>Hafidi, R</creatorcontrib><creatorcontrib>Babahabib, A</creatorcontrib><creatorcontrib>El Hassani, M</creatorcontrib><creatorcontrib>Kaouach, J</creatorcontrib><creatorcontrib>Moussaoui, D</creatorcontrib><creatorcontrib>Dehayni, M</creatorcontrib><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>Engineering Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><jtitle>International journal of innovation and applied studies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benabdjalil, Y</au><au>Mezane, S</au><au>Achenani, M</au><au>Hafidi, R</au><au>Babahabib, A</au><au>El Hassani, M</au><au>Kaouach, J</au><au>Moussaoui, D</au><au>Dehayni, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ]</atitle><jtitle>International journal of innovation and applied studies</jtitle><date>2014-07-01</date><risdate>2014</risdate><volume>7</volume><issue>1</issue><spage>103</spage><pages>103-</pages><eissn>2028-9324</eissn><abstract>The definition of borderline ovarian tumors is pathological. It is based on the combination of several histological criteria established by Hart and Norris and reviewed by Scully et al: pluristratification and epithelial budding, increased mitotic activity which can be very variable, cytonuclear atypia (differential diagnosis with benign tumors), absence of stromal invasion (differential diagnosis of malignant tumors). Serous tumors represent approximately 55% of borderline tumors. They are bilateral in 28-50% of cases. This histological type is, however, more often associated with extra-ovarian locations, as found in 30% of cases on average peritoneal implants, whose detection is fundamental because the class tumor stage III. Staging should be as complete as possible and should be as far as possible during the initial surgical resection. A restaging should be made when the initial staging is incomplete. Restaging does not affect patient survival but used to evaluate the prognosis of the initial tumor. Its indication still remains controversial: it is recommended for early-stage tumors, for which the treatment is now well codified.</abstract><cop>Rabat</cop><pub>International Journal of Innovation and Applied Studies</pub></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2028-9324 |
ispartof | International journal of innovation and applied studies, 2014-07, Vol.7 (1), p.103 |
issn | 2028-9324 |
language | fre |
recordid | cdi_proquest_journals_1556059748 |
source | EZB-FREE-00999 freely available EZB journals |
title | Tumeur séreuse borderline sur ovaires restants à propos d'un cas avec revue de la littérature [ Serous borderline tumor of ovary remaining a propos one case and review of the literature ] |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumeur%20s%C3%A9reuse%20borderline%20sur%20ovaires%20restants%20%C3%A0%20propos%20d'un%20cas%20avec%20revue%20de%20la%20litt%C3%A9rature%20%5B%20Serous%20borderline%20tumor%20of%20ovary%20remaining%20a%20propos%20one%20case%20and%20review%20of%20the%20literature%20%5D&rft.jtitle=International%20journal%20of%20innovation%20and%20applied%20studies&rft.au=Benabdjalil,%20Y&rft.date=2014-07-01&rft.volume=7&rft.issue=1&rft.spage=103&rft.pages=103-&rft.eissn=2028-9324&rft_id=info:doi/&rft_dat=%3Cproquest%3E3413222031%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1556059748&rft_id=info:pmid/&rfr_iscdi=true |